Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
R. López-Vélez.
Enfermedades infecciosas tropicales en el niño inmigrante.
Rev Esp Pediatr, 54 (1998), pp. 149-161
[2.]
Centers for Disease Control and Prevention.
Recommendation of the Advisory Committee on Immunization Practices (ACIP): Use of BCG vaccine in the control of tuberculosis: ? joint statement by the ACIP and the Advisory Committee for elimination of tuberculosis.
MMWR, 37 (1988), pp. 663-669
[3.]
J. Alcaide, M.N. Alter, Li Salleras.
Vacuna BCG.
Vacunaciones preventivas. Principio y aplicaciones, pp. 405-444
[4.]
N. Kuyucu, S. Kuyucu.
Comparison of oral erythromycin, local administration of estreptomycin and placebo. Therapy for nonsuppurative bacillus calmethelymphadenitis.
Pediatr Infect Dis J, 17 (1998), pp. 524-525
[5.]
Z. Katzir, E. Okon, A. Ludmirski, Y. Sherman, H. Hass.
Generalized lymphadenitis following BCG vaccination in an inmunocompetent 12 year old boy.
Eur J Pediatr, 141 (1984), pp. 165-167
[6.]
P. Hengster, B. Solder, M. Fille, G. Menardi.
Surgical treatment of bacillus Calmette-Guérin lymphadenitis.
World J Surg, 25 (1997), pp. 520-523
[7.]
J.M. Fitgerald.
Management of adverse reactions to bacille Calmette-Guérin vaccine.
Clin Infect Dis, 31 (2000), pp. S75-S76
[8.]
H.E. Pabst, J.C. Godel, D.W. Spady, J. McKechie, M. Grace.
Prospective trial of timing of bacillus Calmette-Guérin vaccination in Canadian Cree infants.
Am Rev Respir Dis, 140 (1989), pp. 1007-1011
[9.]
J.B. Milstien, J.J. Milstien.
Quality control of BCG vaccine by WHO: ? review of factors that may influence vaccine effectiveness and safety.
Bull World Health Organ, 68 (1990), pp. 93-108
Copyright © 2003. Asociación Española de Pediatría
